亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Dental Adverse Effects of Anti-CD20 Therapies

医学 奥图穆马 美罗华 奥克列珠单抗 芬戈莫德 神经学 视神经脊髓炎 多发性硬化 皮肤病科 不利影响 重症肌无力 重症监护医学 内科学 免疫学 精神科 淋巴瘤
作者
Hélène Bartak,Tasnim Fareh,Nouha Ben-Othman,Delphine Viard,Mikaël Cohen,Fanny Rocher,Elliot Ewig,Milou‐Daniel Drici,Christine Lebrun‐Frénay
出处
期刊:Neurology and Therapy [Adis, Springer Healthcare]
卷期号:13 (3): 917-930 被引量:9
标识
DOI:10.1007/s40120-024-00616-7
摘要

INTRODUCTION: Over the past few years, anti-CD20 therapies like rituximab, ocrelizumab or ofatumumab have seen an increase in interest in the treatment of neurological autoimmune disorders such as multiple sclerosis (MS), neuromyelitis optica spectrum disorders (NMOSD), or resistant forms of generalized myasthenia gravis (MG). They are generally well-tolerated, but recent reports have highlighted severe dental disorders in patients undergoing anti-CD20 therapies. The aim was to describe a series of cases and to compare with the available scientific literature. METHODS: We reviewed 6 patient cases with dental disorders during anti-CD20 therapy that were reported to the pharmacovigilance center. A disproportionality analysis was also conducted on Vigibase® for each anti-CD20 and each adverse effect described in the cases. RESULTS: Six cases of dental and gingival conditions in relatively young patients were reported (median age: 40.5 years old [min: 34; max: 79]). Oral conditions were developed in four patients with MS treated with ocrelizumab and in two patients receiving rituximab (one patient with MG and one with NMOSD). The onset of oral conditions ranged from 10 days to 2 years after treatment initiation. Notably, all patients treated with ocrelizumab experienced gingival recession. Various dental pathologies were observed, including tooth loss, dental pain, caries, brittle teeth, dental fractures, dental abscesses, and periodontitis. Analysis of Vigibase® revealed 284 worldwide cases of dental and gingival conditions under ocrelizumab, 386 cases under rituximab, and 80 under ofatumumab. Significant associations were found between these therapies and dental pathologies, particularly tooth abscesses and infections. CONCLUSION: To our knowledge, this is the first case series reporting dental conditions developed in patients long-term treated with anti-CD20 treatments. This issue, literature data, and Vigilyze® analysis might be considered a safety signal that necessitates being confirmed with more robust data, such as a retrospective study with a control group. Meanwhile, proactive measures are essential like frequent dental checkups and dental hygienic measures to prevent oral health problems associated with anti-CD20 therapies.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zilicai的应助被冷阳采纳,获得10
8秒前
25秒前
如意大神完成签到,获得积分10
26秒前
30秒前
寒冷的月亮完成签到 ,获得积分10
33秒前
34秒前
落后的雪青完成签到,获得积分10
46秒前
50秒前
55秒前
YYY发布了新的文献求助10
56秒前
Maestro_S的应助被Heaven采纳,获得10
57秒前
57秒前
MT完成签到,获得积分10
1分钟前
光亮的成败完成签到,获得积分10
1分钟前
1分钟前
快乐夜阑完成签到,获得积分10
1分钟前
完美世界的应助被Heaven采纳,获得10
1分钟前
1分钟前
Shicheng完成签到,获得积分10
1分钟前
zhiwei完成签到,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
腼腆的乘云完成签到,获得积分10
1分钟前
Ttimer发布了新的文献求助10
1分钟前
自觉康乃馨完成签到,获得积分10
1分钟前
ZYP完成签到,获得积分10
1分钟前
受伤若男完成签到,获得积分10
2分钟前
2分钟前
拉长的映波完成签到,获得积分10
2分钟前
yoshi发布了新的文献求助10
2分钟前
2分钟前
yoshi完成签到,获得积分10
2分钟前
搜集达人的应助被yoshi采纳,获得10
2分钟前
3分钟前
公冶愚志完成签到 ,获得积分10
3分钟前
3分钟前
失眠晟睿完成签到,获得积分10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179920
求助须知:如何正确求助?哪些是违规求助? 9570103
关于积分的说明 21808354
捐赠科研通 7775701
什么是DOI,文献DOI怎么找? 3433193
关于科研通互助平台的介绍 2557347
邀请新用户注册赠送积分活动 2478918